REG - GlaxoSmithKline PLC - Director/PDMR Shareholding

GSKAnnouncement

20/02/2019 14:45

RNS Number : 6485Q
GlaxoSmithKline PLC
20 February 2019
 


GlaxoSmithKline plc (the 'Company')
Transaction notification




1.


Details of PDMR/person closely associated with them ('PCA')




a)


Name


Mr J Ford




b)


Position/status


SVP & General Counsel




c)


Initial notification/
amendment


Initial notification




2.


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name


GlaxoSmithKline plc




b)


LEI


5493000HZTVUYLO1D793




3.


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted




a)


Description of the financial instrument


GlaxoSmithKline plc American Depositary Shares ('ADSs')
ISIN: US37733W1053
 




b)


Nature of the transaction


The exercise of options over 11,870 ADSs, granted on 22 February 2010 under the GlaxoSmithKline Share Option Plan, at an option price of $37.32.




c)


Price(s) and volume(s)






Price(s)


Volume(s)




$37.32


2,679 (Incentive Stock Option)




$37.32


9,191 (Non-Qualified Stock Option)




 




d)


Aggregated information
 
Aggregated volume Price










11,870

$37.32




e)


Date of the transaction


2019-02-19




f)


Place of the transaction
 


n/a




 
 
 




1.


Details of PDMR/person closely associated with them ('PCA')




a)


Name


Mr J Ford




b)


Position/status


SVP & General Counsel




c)


Initial notification/
amendment


Initial notification




2.


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name


GlaxoSmithKline plc




b)


LEI


5493000HZTVUYLO1D793




3.


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted




a)


Description of the financial instrument


GlaxoSmithKline plc American Depositary Shares ('ADSs')
ISIN: US37733W1053
 




b)


Nature of the transaction


The sale of 11,870 ADSs, granted on 22 February 2010 under the GlaxoSmithKline Share Option Plan.




c)


Price(s) and volume(s)






Price(s)


Volume(s)




$41.22


2,679 (Incentive Stock Option)




$41.22


9,191 (Non-Qualified Stock Option)




 




d)


Aggregated information
 
Aggregated volume Price










11,870

$41.22




e)


Date of the transaction


2019-02-19




f)


Place of the transaction
 


New York Stock Exchange (XNYS)




 
 
 
 
 




1.


Details of PDMR/person closely associated with them ('PCA')




a)


Name


Mr J Ford




b)


Position/status


SVP & General Counsel




c)


Initial notification/
amendment


Initial notification




2.


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name


GlaxoSmithKline plc




b)


LEI


5493000HZTVUYLO1D793




3.


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted




a)


Description of the financial instrument


GlaxoSmithKline plc American Depositary Shares ('ADSs')
ISIN: US37733W1053
 




b)


Nature of the transaction


The sale of ADSs




c)


Price(s) and volume(s)






Price(s)


Volume(s)




$41.22


11,884




 




d)


Aggregated information
 
Aggregated volume Price


n/a (single transaction)




e)


Date of the transaction


2019-02-19




f)


Place of the transaction
 


New York Stock Exchange (XNYS)




 
 
 
 
 




1.


Details of PDMR/person closely associated with them ('PCA')




a)


Name


Mr J Ford




b)


Position/status


SVP & General Counsel




c)


Initial notification/
amendment


Initial notification




2.


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name


GlaxoSmithKline plc




b)


LEI


5493000HZTVUYLO1D793




3.


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted




a)


Description of the financial instrument


Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882 
 




b)


Nature of the transaction


Sale of Ordinary Shares
 




c)


Price(s) and volume(s)






Price(s)


Volume(s)




£15.66


1




 
 




d)


Aggregated information
 
Aggregated volume Price


n/a (single transaction)
 
 
 
 
 
 




e)


Date of the transaction


2019-02-19




f)


Place of the transaction
 


London Stock Exchange (XLON)




 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHZBLFLKLFXBBK